English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/208089
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Gold as a possible alternative to platinum-based chemotherapy for colon cancer treatment

AuthorsMármol, Inés; Quero, Javier; Rodríguez-Yoldi, Mª. Jesus; Cerrada, Elena
Keywordscolorectal cancer
gold(I) complexes
thioredoxin reductase
reactive oxygen species
gold nanoparticles
theragnosis
photodynamic therapy
photothermal therapy
radiotherapy
Issue Date5-Jun-2019
PublisherMultidisciplinary Digital Publishing Institute
CitationCancers 11(6): 780 (2019)
AbstractDue to the increasing incidence and high mortality associated with colorectal cancer (CRC), novel therapeutic strategies are urgently needed. Classic chemotherapy against CRC is based on oxaliplatin and other cisplatin analogues; however, platinum-based therapy lacks selectivity to cancer cells and leads to deleterious side effects. In addition, tumor resistance to oxaliplatin is related to chemotherapy failure. Gold(I) derivatives are a promising alternative to platinum complexes, since instead of interacting with DNA, they target proteins overexpressed on tumor cells, thus leading to less side effects than, but a comparable antitumor effect to, platinum derivatives. Moreover, given the huge potential of gold nanoparticles, the role of gold in CRC chemotherapy is not limited to gold(I) complexes. Gold nanoparticles have been found to be able to overcome multidrug resistance along with reduced side effects due to a more efficient uptake of classic drugs. Moreover, the use of gold nanoparticles has enhanced the effect of traditional therapies such as radiotherapy, photothermal therapy, or photodynamic therapy, and has displayed a potential role in diagnosis as a consequence of their optic properties. Herein, we have reviewed the most recent advances in the use of gold(I) derivatives and gold nanoparticles in CRC therapy.
Publisher version (URL)http://doi.org/10.3390/cancers11060780
URIhttp://hdl.handle.net/10261/208089
DOI10.3390/cancers11060780
Identifiersdoi: 10.3390/cancers11060780
e-issn: 2072-6694
Appears in Collections:(ISQCH) Artículos
Files in This Item:
File Description SizeFormat 
gold_Platinum_Chemotherapy_Colon_Cancer_Treatment.pdf2,08 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.